Subarachnoid Space Transplantation of Schwann and/or Olfactory Ensheathing Cells Following Severe Spinal Cord Injury	1
Subarachnoid Space Transplantation	1
Schwann and/or Olfactory Ensheathing Cells	39
Severe Spinal Cord Injury	92
Locomotor Recovery in Rats Abstract	135
Locomotor Recovery	135
Rats Abstract	157
Treatment of spinal cord injury by exogenous cells	173
Treatment	173
spinal cord injury by exogenous cells	186
spinal cord injury	186
exogenous cells	208
both successful and unsuccessful results	236
Olfactory ensheathing cells and Schwann cells	278
transplantation purposes	350
this study	379
we	391
the effects of these cells	407
the effects	407
these cells	422
spinal cord	446
cells	473
subarachnoid space	484
Fifty thousand Schwann cells or olfactory ensheathing cells or a mixture of both cell types	504
Fifty thousand Schwann cells or olfactory ensheathing cells	504
a mixture of both cell types	567
a mixture	567
both cell types	580
transplanted one week	601
a 3-second clip compression injury at T-9 spinal cord level in rats	629
a 3-second clip compression injury	629
T-9 spinal cord level	667
rats	692
the day one of spinal cord injury	712
the day one	712
spinal cord injury	727
animals	747
six months	773
BBB test	787
immunohistochemistry labeling of the spinal cord injury site	825
immunohistochemistry labeling	825
the spinal cord injury site	858
There	887
no locomotor recovery in any of the treatment groups including controls	897
no locomotor recovery	897
any of the treatment groups including controls	922
any	922
the treatment groups including controls	929
the treatment groups	929
controls	960
Immunohistochemistry assessment	970
positive labeling of P75 and S100 markers	1012
positive labeling	1012
P75 and S100 markers	1033
the cell-transplanted groups compared with control	1057
the cell-transplanted groups	1057
control	1100
Our data suggest that transplantation of Schwann cells and/or olfactory ensheathing cells into the subarachnoid space	1109
Our data	1109
transplantation of Schwann cells	1131
transplantation	1131
Schwann cells	1150
olfactory ensheathing cells	1171
the subarachnoid space	1204
motor recovery	1244
severely injured spinal cord	1262
the number of cells transplanted here	1306
the number	1306
cells transplanted here	1320
cells	1320
This	1345
an essentially negative outcome	1386
further studies which consider higher densities of cells	1423
further studies	1423
higher densities of cells	1454
higher densities	1454
cells	1474
Introduction Transplantation of Schwann cell and Olfactory Ensheathing Cell -LRB- OEC -RRB-	1495
Introduction Transplantation	1495
Schwann cell and Olfactory Ensheathing Cell -LRB- OEC -RRB-	1527
Schwann cell and Olfactory Ensheathing Cell	1527
OEC	1572
promising results	1587
animal models of spinal cord injury -LRB- 1-3 -RRB-	1608
animal models	1608
spinal cord injury -LRB- 1-3 -RRB-	1625
spinal cord injury	1625
1-3	1645
These cells	1651
functions such as secretion of growth factors , axon guidance , myelination and structural support	1668
functions	1668
secretion of growth factors , axon guidance , myelination and structural support	1686
secretion	1686
growth factors , axon guidance , myelination and structural support	1699
growth factors	1699
axon guidance	1715
myelination	1730
structural support	1746
4	1766
Previous studies	1770
these two cell types	1800
the demyelinated CNS -LRB- 5 -RRB-	1883
the	1883
CNS -LRB- 5 -RRB-	1900
CNS	1900
5	1905
Transplantation of Schwann cell in injured spinal cord	1909
Transplantation	1909
Schwann cell in injured spinal cord	1928
Schwann cell	1928
injured spinal cord	1944
beneficial results	1976
the functional and structural recovery of spinal cord lesions	1998
the functional and structural recovery	1998
spinal cord lesions	2040
6-10	2061
Other studies	2068
evidence	2090
transplantation of OECs	2104
transplantation	2104
OECs	2123
motor function	2137
contusion -LRB- 11,12 -RRB- or transection models -LRB- 13,14 -RRB-	2162
contusion -LRB- 11,12 -RRB-	2162
contusion	2162
11,12	2173
transection models -LRB- 13,14 -RRB-	2183
transection models	2183
13,14	2203
OEC	2211
functional properties of lesioned dorsal column in an animal model of spinal cord injury -LRB- 15 -RRB-	2229
functional properties	2229
lesioned dorsal column in an animal model of spinal cord injury -LRB- 15 -RRB-	2254
lesioned dorsal column	2254
an animal model of spinal cord injury -LRB- 15 -RRB-	2280
an animal model	2280
spinal cord injury -LRB- 15 -RRB-	2299
spinal cord injury	2299
15	2319
these cells	2333
regeneration purposes -LRB- 5,16-19 -RRB-	2375
regeneration purposes	2375
5,16-19	2398
results	2430
the use of Schwann cell and OEC in experimental spinal cord injury models	2441
the use	2441
Schwann cell and OEC in experimental spinal cord injury models	2452
Schwann cell and OEC	2452
experimental spinal cord injury models	2476
they	2516
best candidates	2539
the purpose of cell therapy -LRB- 20 -RRB-	2559
the purpose	2559
cell therapy -LRB- 20 -RRB-	2574
cell therapy	2574
20	2588
The idea of a combination of Schwann cell and OEC for spinal cord injury transplantation	2593
The idea	2593
a combination of Schwann cell and OEC for spinal cord injury transplantation	2605
a combination	2605
Schwann cell and OEC for spinal cord injury transplantation	2622
Schwann cell and OEC	2622
spinal cord injury transplantation	2647
their specifications	2698
example	2724
OECs	2733
a better ability	2743
migration	2764
astrocytes	2801
them	2847
the case for Schwann cells -LRB- 5 -RRB-	2859
the case	2859
Schwann cells -LRB- 5 -RRB-	2872
Schwann cells	2872
5	2887
Schwann cells , on the other hand ,	2891
Schwann cells	2891
the other hand	2909
axonal growth and myelination -LRB- 4 -RRB-	2963
axonal growth and myelination	2963
4	2994
There	2998
a few studies which used OEC and Schwann cell in combination -LRB- 8,21,22 -RRB-	3008
a few studies	3008
OEC and Schwann cell	3033
combination -LRB- 8,21,22 -RRB-	3057
combination	3057
8,21,22	3070
It	3080
OEC	3106
beneficial effects	3117
Schwann cells	3139
combination -LRB- 23 -RRB-	3174
combination	3174
23	3187
We	3192
transplantation of Schwann cell through subarachnoid route	3222
transplantation	3222
Schwann cell through subarachnoid route	3241
Schwann cell	3241
subarachnoid route	3262
motor performance	3290
moderate spinal cord contusion in rats -LRB- 24 -RRB-	3311
moderate spinal cord contusion	3311
rats -LRB- 24 -RRB-	3345
rats	3345
24	3351
our human study	3360
such improvement	3392
transplanted cases -LRB- 25 -RRB-	3412
transplanted cases	3412
25	3432
very severe injuries of spinal cord	3458
very severe injuries	3458
spinal cord	3482
our previous study -LRB- 24 -RRB-	3506
our previous study	3506
24	3526
we	3531
subarachnoid transplantation of OEC and Schwann cell , alone	3547
subarachnoid transplantation of OEC and Schwann cell	3547
subarachnoid transplantation	3547
OEC and Schwann cell	3579
combination	3613
spinal cord of rat	3638
spinal cord	3638
rat	3653
behavioral recovery	3672
long-term	3695
Materials and Methods Study design A total number of sixty female inbred Wistar rats weighing 180-200 g	3707
Materials	3707
Methods Study design A total number of sixty female inbred Wistar rats weighing 180-200 g	3721
Methods Study design A total number	3721
Methods	3721
Study design	3729
A total number	3742
sixty female inbred Wistar rats weighing 180-200 g	3760
sixty female inbred Wistar rats	3760
180-200 g	3801
seven groups of Control -LRB- n = 8 -RRB- , sham-operated -LRB- n = 4 -RRB- , DMEM -LRB- n = 8 -RRB- , OEC -LRB- n = 10 -RRB- , Schwann -LRB- n = 10 -RRB- , Mixed -LRB- OEC+S chwann , n = 10 -RRB- and fibroblast -LRB- n = 10 -RRB- based on injected suspension	3838
seven groups	3838
Control -LRB- n = 8 -RRB- , sham-operated -LRB- n = 4 -RRB- , DMEM -LRB- n = 8 -RRB- , OEC -LRB- n = 10 -RRB- , Schwann -LRB- n = 10 -RRB- , Mixed -LRB- OEC+S chwann , n = 10 -RRB- and fibroblast -LRB- n = 10 -RRB- based on injected suspension	3854
Control -LRB- n = 8 -RRB- , sham-operated -LRB- n = 4 -RRB- , DMEM -LRB- n = 8 -RRB- , OEC -LRB- n = 10 -RRB- , Schwann -LRB- n = 10 -RRB- , Mixed -LRB- OEC+S chwann , n = 10 -RRB- and fibroblast -LRB- n = 10 -RRB-	3854
Control -LRB- n = 8 -RRB-	3854
Control	3854
n	3863
8	3865
sham-operated -LRB- n = 4 -RRB-	3869
sham-operated	3869
n	3884
4	3886
DMEM -LRB- n = 8 -RRB-	3890
DMEM	3890
n	3896
8	3898
OEC -LRB- n = 10 -RRB-	3902
OEC	3902
n	3907
10	3909
Schwann -LRB- n = 10 -RRB-	3914
Schwann	3914
n	3923
10	3925
Mixed -LRB- OEC+S chwann , n = 10 -RRB-	3930
Mixed	3930
OEC+S chwann , n = 10	3937
OEC+S chwann	3937
n = 10	3950
n	3950
10	3952
fibroblast -LRB- n = 10 -RRB-	3960
fibroblast	3960
n	3972
10	3974
injected suspension	3987
All procedures	4008
the guidelines of ethics committee of Tehran University of Medical Sciences	4053
the guidelines	4053
ethics committee of Tehran University of Medical Sciences	4071
ethics committee	4071
Tehran University of Medical Sciences	4091
Tehran University	4091
Medical Sciences	4112
Behavioral recovery of animals	4130
Behavioral recovery	4130
animals	4153
BBB locomotor rating scale for six months -LRB- 26 -RRB-	4177
BBB locomotor rating scale	4177
six months -LRB- 26 -RRB-	4208
six months	4208
26	4220
Animals	4225
histology and immunohistochemistry assessments	4271
Spinal cord injury Aseptic surgical procedures	4319
Spinal cord injury	4319
Aseptic surgical procedures	4338
anesthesia induced by a mixture of Ketamine -LRB- 100 mg/kg , ip -RRB- and Xylazine -LRB- 10 mg/kg , ip -RRB-	4387
anesthesia	4387
a mixture of Ketamine -LRB- 100 mg/kg , ip -RRB- and Xylazine -LRB- 10 mg/kg , ip -RRB-	4409
a mixture	4409
Ketamine -LRB- 100 mg/kg , ip -RRB- and Xylazine -LRB- 10 mg/kg , ip -RRB-	4422
Ketamine	4422
100 mg/kg , ip	4432
100 mg/kg	4432
ip	4443
Xylazine	4451
10 mg/kg , ip	4461
10 mg/kg	4461
ip	4471
anesthesia , assessed by corneal reflex	4486
anesthesia	4486
corneal reflex	4510
an incision	4526
skin	4555
T4-T12 thoracic vertebra	4569
Laminectomy	4595
the T9-T10 level	4624
loupe magnification	4647
A curved aneurysm clip with closing force of 1.23 N	4668
A curved aneurysm clip	4668
closing force of 1.23 N	4696
closing force	4696
1.23 N	4713
the cord for three seconds	4741
the cord	4741
three seconds	4754
lower and upper blades of the clip compressing ventral and dorsal surfaces of the cord	4774
lower and upper blades	4774
the clip compressing ventral and dorsal surfaces of the cord	4800
the clip	4800
ventral and dorsal surfaces of the cord	4821
ventral and dorsal surfaces	4821
the cord	4852
Flanking muscles and skin	4862
Flanking muscles	4862
skin	4883
4-0 chromic catgut and silk sutures	4910
Normal saline solution	4960
the surgery -LRB- 5 ml , ip -RRB-	5002
the surgery	5002
5 ml , ip	5015
5 ml	5015
ip	5021
animals	5029
recovery cages	5057
Aspirin	5073
drinking water -LRB- 100 mg/L -RRB-	5098
drinking water	5098
100 mg/L	5114
three days as an analgesic	5141
three days	5141
an analgesic	5155
Special care	5169
twice-a-day bladder expression and subcutaneous injection of Cefazolin -LRB- 150 mg/kg -RRB- and Gentamicin -LRB- 5 mg/kg -RRB-	5191
twice-a-day bladder expression and subcutaneous injection	5191
Cefazolin -LRB- 150 mg/kg -RRB- and Gentamicin -LRB- 5 mg/kg -RRB-	5252
Cefazolin	5252
150 mg/kg	5263
Gentamicin	5278
5 mg/kg	5290
two months in cases	5309
two months	5309
cases	5323
animals	5335
urination	5367
urinary tract infection	5385
Cell preparation OEC and Schwann cell cultures	5423
Cell preparation OEC	5423
Schwann cell cultures	5448
the olfactory bulb and sciatic nerve of neonatal rats inbred with recipient animals	5489
the olfactory bulb and sciatic nerve	5489
neonatal rats inbred with recipient animals	5529
neonatal rats	5529
recipient animals	5555
Schwann cells	5588
a protocol described previously with some modifications -LRB- 24,27 -RRB-	5619
a protocol	5619
some modifications -LRB- 24,27 -RRB-	5656
some modifications	5656
24,27	5676
sciatic nerves	5693
5-day-old rats	5734
the epineurium	5750
the nerve	5782
several explants where subsequently placed on poly-L-lysine coated plates filled with culture media -LRB- DMEM +10 % FCS -RRB-	5807
several explants	5807
poly-L-lysine coated plates filled with culture media	5853
poly-L-lysine coated plates	5853
culture media	5893
DMEM +10 % FCS	5908
DMEM	5908
+10 % FCS	5912
+10 %	5912
FCS	5917
fibroblast contamination	5942
explants	5968
3 to 4 times	5994
four weeks	6014
The cold jet technique	6026
the purity of the Schwann cells	6073
the purity	6073
the Schwann cells	6087
this way	6109
our cultures	6119
a purity of about 95 % determined by labeling with the anti-S100 antibody -LRB- 28 -RRB-	6136
a purity	6136
95 % determined by labeling with the anti-S100 antibody -LRB- 28 -RRB-	6154
95 %	6154
the anti-S100 antibody -LRB- 28 -RRB-	6186
the anti-S100 antibody	6186
28	6210
fibroblast contamination	6221
we	6261
a seventh group	6270
the effect of pure fibroblast transplantation	6298
the effect	6298
pure fibroblast transplantation	6312
Purification of OEC	6345
Purification	6345
OEC	6361
the method of Nash	6382
the method	6382
Nash	6396
et al. , -LRB- 29 -RRB-	6401
et al.	6401
29	6410
Briefly olfactory bulbs from neonates	6415
Briefly olfactory bulbs	6415
neonates	6444
the nerve fiber layer	6473
Cell suspension	6531
18 hours	6561
the supernatant	6580
a second plate which incubated for 36 hours	6615
a second plate	6615
36 hours	6650
The remaining supernatant	6660
poly-L-lysine coated plates	6707
cells	6756
a confluency of 70-80 %	6770
a confluency	6770
70-80 %	6786
Cell transplantation	6794
One week	6815
spinal cord injury	6830
injury site	6850
cell transplantation	6880
Scar tissue	6902
care	6932
the exposed dura mater	6961
The suspension for injection of either OEC or Schwann cells	6985
The suspension	6985
injection of either OEC or Schwann cells	7004
injection	7004
either OEC or Schwann cells	7017
OEC	7024
Schwann cells	7031
5 × 104 cells of each in 5 μL of DMEM	7055
5 × 104 cells	7055
each in 5 μL of DMEM	7070
each	7070
5 μL of DMEM	7078
5 μL	7078
DMEM	7086
the mixed suspension	7100
a half concentration of each	7122
a half concentration	7122
each	7146
Fibroblasts , with a similar concentration ,	7165
Fibroblasts	7165
a similar concentration	7183
Cell suspensions	7228
the subarachnoid space	7264
10 seconds using a Hamilton syringe with a fine 30-gauge needle bent in the middle to minimize unwanted tissue damage	7294
10 seconds	7294
a Hamilton syringe	7311
a fine 30-gauge needle bent in the middle to minimize unwanted tissue damage	7335
a fine 30-gauge needle bent	7335
the middle to minimize unwanted tissue damage	7366
unwanted tissue	7389
The needle tip	7413
the dura mater 3-4 mm caudal from the injury epicenter	7446
the dura mater 3-4 mm caudal	7446
the injury epicenter	7480
its bent portion distance	7524
injection	7557
the needle	7568
10 seconds	7598
leakage of the suspension	7621
leakage	7621
the suspension	7632
Behavioral assessment Assessment of hindlimb function using Basso , Beattie , Bresnahan -LRB- BBB -RRB- locomotor rating scale was performed every week for nine weeks and afterward , twice or once a month until 160 days post-injury , by two examiners	7677
Behavioral assessment Assessment	7677
hindlimb function using Basso , Beattie , Bresnahan -LRB- BBB -RRB- locomotor rating scale was performed every week for nine weeks and afterward , twice or once a month until 160 days post-injury , by two examiners	7713
hindlimb function	7713
Basso , Beattie , Bresnahan -LRB- BBB -RRB- locomotor rating scale was performed every week for nine weeks and afterward , twice or once	7737
Basso , Beattie , Bresnahan	7737
BBB	7764
locomotor rating scale	7769
every week	7806
nine weeks	7821
a month	7861
160 days	7875
two examiners	7900
the animal treatment -LRB- 26,27 -RRB-	7925
the animal treatment	7925
26,27	7947
this purpose	7959
animals	7973
a round plastic container with a diameter and wall of 85 and 30 centimeters	7996
a round plastic container	7996
a diameter and wall of 85 and 30 centimeters	8027
a diameter and wall	8027
85 and 30 centimeters	8050
Immunohistochemistry	8087
the end of the study	8111
the end	8111
the study	8122
all surviving animals	8133
4 % paraformaldehyde	8189
Two-centimeter segments of spinal cord containing the center of the lesion in the middle	8210
Two-centimeter segments	8210
spinal cord containing the center of the lesion in the middle	8237
spinal cord	8237
the center of the lesion in the middle	8260
the center	8260
the lesion in the middle	8274
the lesion	8274
the middle	8288
paraffin	8332
3 μm	8356
rehydration	8369
the sections	8382
antigen retrieval	8405
slides	8424
a humidified chamber	8446
a solution of hydrogen peroxide	8483
a solution	8483
hydrogen peroxide	8497
methanol -LRB- 1:9 -RRB- for 20 minutes	8520
methanol -LRB- 1:9 -RRB-	8520
methanol	8520
1:9	8530
20 minutes	8539
distilled water	8574
slides	8591
Tris solution -LRB- pH = 6 -RRB-	8616
Tris solution	8616
pH	8631
6	8634
120 ° C for 15 minutes	8640
120 ° C	8640
15 minutes	8651
Blocking	8663
normal donkey serum -LRB- 1:10 -RRB- for 30 minutes	8689
normal donkey serum -LRB- 1:10 -RRB-	8689
normal donkey serum	8689
1:10	8710
30 minutes	8720
Anti-P75 -LRB- rabbit polyclonal , 1:500 ; Sigma -RRB- and anti-S100 -LRB- S2644 ; rabbit polyclonal , 1:500 ; Sigma -RRB- antibodies	8732
Anti-P75 -LRB- rabbit polyclonal , 1:500 ; Sigma -RRB-	8732
Anti-P75	8732
rabbit	8742
polyclonal , 1:500 ; Sigma	8749
polyclonal	8749
1:500	8761
Sigma	8768
anti-S100 -LRB- S2644 ; rabbit polyclonal , 1:500 ; Sigma -RRB- antibodies	8779
anti-S100	8779
S2644 ; rabbit polyclonal	8790
S2644	8790
rabbit polyclonal	8797
1:500 ; Sigma	8816
1:500	8816
Sigma	8823
antibodies	8830
1 hour at room temperature	8855
1 hour	8855
room temperature	8865
Sections	8883
Tris/Tween 20 solution	8912
10 minutes	8939
HRP-conjugated secondary antibody	8956
the sections	9011
30 minutes at room temperature	9028
30 minutes	9028
room temperature	9042
another wash with Tris/Tween 20	9066
another wash	9066
Tris/Tween 20	9084
diaminobenzidine tetrahydrochloride -LRB- DAB -RRB-	9099
diaminobenzidine tetrahydrochloride	9099
DAB	9136
the chromogen for up to 10 minutes	9161
the chromogen	9161
up to 10 minutes	9179
all specimens	9206
Hematoxylin	9245
Slides	9258
light microscope	9315
a separate staining	9336
every four sections	9357
Hematoxylin and Eosin -LRB- H and E -RRB-	9395
Hematoxylin and Eosin	9395
H and E	9418
H	9418
E	9424
a pathologist for gliosis and inflammation	9443
a pathologist	9443
gliosis and inflammation	9461
Statistical analysis Statistical comparisons of BBB scores between experimental groups	9487
Statistical analysis Statistical comparisons	9487
BBB scores between experimental groups	9535
BBB scores	9535
experimental groups	9554
two-way analysis of variances -LRB- ANOVA -RRB-	9595
two-way analysis	9595
variances -LRB- ANOVA -RRB-	9615
variances	9615
ANOVA	9626
A P.value	9634
0.05	9654
this study	9689
Results Figure 1 .	9702
Results	9702
Figure 1	9710
Mean of BBB scores -LRB- ± SEM -RRB- of the all experimental groups .	9720
Mean	9720
BBB scores	9728
± SEM	9740
the all experimental groups	9749
Animals	9778
one week	9800
the injury	9818
all	9834
21 , which is considered normal locomotion	9845
21	9845
normal locomotion	9869
the higher score of fibroblast group at the third week -LRB- * P < 0.05 -RRB-	9895
the higher score	9895
fibroblast group at the third week -LRB- * P < 0.05 -RRB-	9915
fibroblast group	9915
the third week -LRB- * P < 0.05 -RRB-	9935
the third week	9935
P <	9952
P	9952
<	9953
0.05	9954
there	9961
no significant difference between the experimental groups during the study	9970
no significant difference	9970
the experimental groups during the study	10004
the experimental groups	10004
the study	10035
Figure 2 .	10047
Figure	10047
2	10054
Injury site of spinal cord showing a portion of the white matter .	10057
Injury site of spinal cord	10057
Injury site	10057
spinal cord	10072
a portion of the white matter	10092
a portion	10092
the white matter	10105
Immunochemistry against P75 and S100	10123
Immunochemistry	10123
P75 and S100	10147
the enzymatic HRP-tagged secondary antibody	10178
Arrows	10223
cells which stained positively for either P75 -LRB- B and C -RRB- or S100 -LRB- D -RRB-	10235
cells	10235
either P75 -LRB- B and C -RRB- or S100 -LRB- D -RRB-	10270
either P75	10270
B and C	10282
B	10282
C	10288
S100	10294
D	10300
A : Anti-P75	10304
Anti-P75	10307
an animal	10328
the control group	10343
No positive staining	10362
B : Anti-P75 positively stains a cell in an animal which received OEC .	10395
B	10395
Anti-P75 positively stains a cell in an animal which received OEC	10398
Anti-P75 positively stains a cell	10398
Anti-P75	10398
stains a cell	10418
stains	10418
a cell	10425
an animal which received OEC	10435
an animal	10435
OEC	10460
C and D : Positive staining of both anti-P75 -LRB- C -RRB- and anti-S100 -LRB- D -RRB- in an animal which received Schwann cell .	10465
C and D	10465
Positive staining of both anti-P75 -LRB- C -RRB- and anti-S100 -LRB- D -RRB- in an animal which received Schwann cell	10474
Positive staining	10474
both anti-P75 -LRB- C -RRB- and anti-S100 -LRB- D -RRB-	10495
both anti-P75	10495
C	10510
anti-S100	10517
D	10528
an animal which received Schwann cell	10534
an animal	10534
Schwann cell	10559
Scale bar : 10 μm .	10573
Scale bar	10573
10 μm	10584
Eight animals	10592
the study	10618
their records	10633
the analysis of data	10668
the analysis	10668
data	10684
the injury	10699
all animals	10711
21	10735
the BBB scale	10751
One day	10766
injury	10780
BBB	10787
seven animals which scored 1 or more in the scale	10810
seven animals	10810
1 or more	10837
the scale	10850
the study	10879
all of the animals	10904
all	10904
the animals	10911
an intensive injury	10931
Other animals	10952
injury criteria	10978
experimental groups	11014
Assessment of BBB score	11035
Assessment	11035
BBB score	11049
one week	11070
21 weeks	11111
no significant difference between the treatment and control groups	11130
no significant difference	11130
the treatment and control groups	11164
this time -LRB- Figure 1 -RRB-	11204
this time	11204
Figure 1	11215
The only exception	11226
the fibroblast group , which showed a slight difference at the third week compared to control , DMEM , OEC , and Schwann cell/OEC groups , but not Schwann cell group	11249
the fibroblast group , which showed a slight difference at the third week compared to control , DMEM , OEC , and Schwann cell/OEC groups ,	11249
the fibroblast group	11249
a slight difference	11284
the third week compared to control	11307
the third week	11307
DMEM , OEC , and Schwann cell/OEC groups	11343
DMEM	11343
OEC	11349
Schwann cell/OEC groups	11358
Schwann cell group	11391
it	11420
BBB score	11425
the fourth week	11447
following evaluations	11470
no difference with any of the groups	11496
no difference	11496
any of the groups	11515
any	11515
the groups	11522
Sham-operated animals	11534
no functional impairment	11563
one week	11588
injury	11603
the time factor in each single group	11644
the time factor	11644
each single group	11663
BBB score	11682
no improvement	11709
even 21 weeks	11724
the injury	11744
H and E stained sections	11759
H and E	11759
sections	11775
fibrosis and gliosis	11785
the injury site	11822
all groups	11841
macrophages	11853
some sections -LRB- data not shown -RRB-	11889
some sections	11889
data not shown	11904
data	11904
the spinal cord with antibodies against P75 or S100	11933
the spinal cord	11933
antibodies against P75 or S100	11954
antibodies	11954
P75 or S100	11973
positive staining	11993
white matter areas of injury site in OEC , Schwann , and mixed groups	12014
white matter areas	12014
injury site in OEC , Schwann , and mixed groups	12036
injury site	12036
OEC , Schwann , and mixed groups	12051
OEC	12051
Schwann	12056
mixed groups	12069
the control and DMEM	12094
groups -LRB- Figure 2 -RRB-	12115
groups	12115
Figure 2	12123
Discussion In this study , we found that transplantation of Schwann cell and/or OEC through the subarachnoid space	12135
Discussion	12135
this study	12149
we	12161
transplantation of Schwann cell	12175
transplantation	12175
Schwann cell	12194
OEC	12214
the subarachnoid space	12226
motor function	12265
rats with severe spinal cord injury	12283
rats	12283
severe spinal cord injury	12293
The only improvement in motor performance	12320
The only improvement	12320
motor performance	12344
the fibroblast group	12374
the third-week post-injury , which followed by an unexpected decline	12398
the third-week post-injury	12398
an unexpected decline	12444
Further studies	12467
the role of exogenous fibroblasts transplanted into the injured cord	12513
the role	12513
exogenous fibroblasts transplanted into the injured cord	12525
exogenous fibroblasts	12525
the injured cord	12565
motor recovery	12592
the ideal goal of most transplantation studies	12610
the ideal goal	12610
most transplantation studies	12628
sensory improvement	12658
this study	12722
several studies of Schwann cell or OEC transplantation	12737
several studies	12737
Schwann cell or OEC transplantation	12756
Schwann cell	12756
OEC transplantation	12772
behavioral recovery	12793
treatment groups -LRB- 8,12,31-34 -RRB-	12828
treatment groups	12828
8,12,31-34	12846
the other hand	12862
it	12878
transplanted Schwann cells	12904
myelinate areas of demyelinated axons	12951
myelinate areas	12951
demyelinated axons	12970
CNS -LRB- 16-19,35 -RRB-	12992
CNS	12992
16-19,35	12997
failure of OEC for improvement of hindlimb function and axon regeneration -LRB- 29,36-39 -RRB- , and even unwanted hyperalgesic effects	13019
failure	13019
OEC for improvement of hindlimb function and axon regeneration -LRB- 29,36-39 -RRB- , and even unwanted hyperalgesic effects	13030
OEC	13030
improvement of hindlimb function and axon regeneration -LRB- 29,36-39 -RRB- , and even unwanted hyperalgesic effects	13038
improvement of hindlimb function and axon regeneration -LRB- 29,36-39 -RRB-	13038
improvement	13038
hindlimb function and axon regeneration -LRB- 29,36-39 -RRB-	13053
hindlimb function and axon regeneration	13053
29,36-39	13094
unwanted hyperalgesic effects	13114
40	13164
A recent human study	13169
improvement	13203
three patients , which suggests that autologous OEC transplantation can be beneficial -LRB- 41 -RRB-	13218
three patients	13218
autologous OEC transplantation	13254
41	13304
most transplantation studies which report improvement in motor function	13312
most transplantation studies	13312
improvement in motor function	13354
improvement	13354
motor function	13369
the weight drop model of spinal cord injury	13385
the weight drop model	13385
spinal cord injury	13410
we	13448
severe clip compression which could be considered complete contusion -LRB- 42 -RRB-	13456
severe clip compression	13456
complete contusion -LRB- 42 -RRB-	13506
complete contusion	13506
42	13526
We	13531
beneficial results in transplantation of Schwann cell	13556
beneficial results	13556
transplantation of Schwann cell	13578
transplantation	13578
Schwann cell	13597
moderate spinal cord contusion	13613
clip compression in rats -LRB- 24 -RRB-	13647
clip compression	13647
rats -LRB- 24 -RRB-	13667
rats	13667
24	13673
The most important difference between our previous study and the current	13678
The most important difference	13678
our previous study and the current	13716
our previous study	13716
the current	13739
the exact contusion model of the spinal cord	13754
the exact contusion model	13754
the spinal cord	13783
the cord	13806
a curved aneurysm clip	13835
the blades	13864
dorsal and ventral surfaces	13905
our previous study	13943
the clip	13962
the blades	13989
lateral surfaces	14011
our previous study	14039
there	14059
a possibility that the most ventral parts of the spinal cord remained intact ; a possibility that was controlled in the current study	14069
a possibility that the most ventral parts of the spinal cord remained intact	14069
a possibility	14069
the most ventral parts of the spinal cord	14088
the most ventral parts	14088
the spinal cord	14114
a possibility that was controlled in the current study	14147
a possibility	14147
the current study	14184
Another point of dissimilarity	14203
Another point	14203
dissimilarity	14220
the 0.07-N	14237
force	14263
the previously-used straight clip	14274
These two factors , position and the closing force of the clip ,	14309
These two factors	14309
position and the closing force of the clip	14328
position	14328
the closing force of the clip	14341
the closing force	14341
the clip	14362
the greater injury seen in this study	14400
the greater injury	14400
this study	14427
the current study	14450
the BBB scores of the control group	14469
the BBB scores	14469
the control group	14487
less than half of those of our previous study	14509
less than half	14509
those of our previous study	14527
those	14527
our previous study	14536
There	14556
factors that potentially affect the outcome of transplantation which vary from cell preparation and engraftment to routes of transplantation	14566
factors	14566
the outcome of transplantation which vary from cell preparation and engraftment to routes of transplantation	14598
the outcome	14598
transplantation	14613
cell preparation and engraftment	14645
routes of transplantation	14681
routes	14681
transplantation	14691
The source of OECs	14708
The source	14708
OECs	14722
the olfactory bulb in this study , which is suggested not to be different from those of olfactory mucosa -LRB- 43 -RRB-	14731
the olfactory bulb	14731
this study , which is suggested not to be different from those of olfactory mucosa -LRB- 43 -RRB-	14753
this study	14753
those of olfactory mucosa	14809
those	14809
olfactory mucosa	14818
43	14836
Survival of transplanted cells	14841
Survival	14841
transplanted cells	14853
another determining factor	14875
another	14875
factor	14895
example in the case of Schwann cell	14907
example	14907
the case of Schwann cell	14918
the case	14918
Schwann cell	14930
it	14944
most cell death	14970
the first 24 hours	14996
even seven days after transplantation , necrosis and apoptosis	15020
even seven days	15020
transplantation , necrosis and apoptosis	15042
44	15095
It	15100
density of cell suspension	15128
density	15128
cell suspension	15139
an important factor in the outcome of transplantation in that high concentration of cells - 50,000 to 100,000 / μlyields better results -LRB- 45 -RRB-	15158
an important factor	15158
the outcome of transplantation in that high concentration of cells - 50,000 to 100,000 / μlyields better results -LRB- 45 -RRB-	15181
the outcome	15181
transplantation in that high concentration of cells - 50,000 to 100,000 / μlyields better results -LRB- 45 -RRB-	15196
transplantation	15196
that high concentration of cells - 50,000 to 100,000 / μlyields better results -LRB- 45 -RRB-	15215
that high concentration	15215
cells - 50,000 to 100,000 / μlyields better results -LRB- 45 -RRB-	15242
cells - 50,000 to 100,000 /	15242
cells	15242
50,000 to 100,000	15249
μlyields better results -LRB- 45 -RRB-	15268
μlyields	15268
better results -LRB- 45 -RRB-	15277
better results	15277
45	15293
a cell population of 50,000 in 5 μL in our study	15304
a cell population	15304
50,000 in 5 μL in our study	15325
50,000	15325
5 μL in our study	15335
5 μL	15335
our study	15343
relatively a sparse transplantation	15356
it	15402
our previous study	15422
Bladder expression and its timing before behavioral assessment	15442
Bladder expression	15442
its timing before behavioral assessment	15465
its timing	15465
behavioral assessment	15483
a potential source of varied results -LRB- 38 -RRB-	15529
a potential source	15529
varied results -LRB- 38 -RRB-	15551
varied results	15551
38	15567
neither the previous nor the current study	15575
the previous	15583
the current study	15600
we	15619
bladder expression	15632
BBB scoring	15660
Part of the recovery from spinal cord injuries	15673
Part	15673
the recovery from spinal cord injuries	15681
the recovery	15681
spinal cord injuries	15699
the plasticity in both spinal cord and higher motor centers -LRB- 46 -RRB-	15734
the plasticity	15734
both spinal cord and higher motor centers -LRB- 46 -RRB-	15752
spinal cord	15757
higher motor centers -LRB- 46 -RRB-	15773
higher motor centers	15773
46	15795
It	15800
a greater injury	15827
less spared tissue	15851
less	15851
tissue	15863
less than 15 percent of the fibers	15876
less than 15 percent	15876
the fibers	15900
plasticity	15921
place	15944
higher centers rostral	15953
higher centers	15953
rostral	15968
the site of injury -LRB- 47 -RRB-	15979
the site	15979
injury -LRB- 47 -RRB-	15991
injury	15991
47	15999
our current intensive injury	16016
the milder injury in our previous study	16046
the milder injury	16046
our previous study	16067
more spared tissue , raising the possibility for greater plasticity with the resultant tangible recovery	16110
more	16110
tissue	16122
the possibility	16138
greater plasticity with the resultant tangible recovery	16158
greater plasticity	16158
the resultant tangible recovery	16182
Immunohistochemical labeling against P75 and S100	16215
Immunohistochemical labeling	16215
P75 and S100	16252
positive labeling in animals	16273
positive labeling	16273
animals	16294
Schwann cell , OEC or both	16311
Schwann cell	16311
OEC	16325
both	16332
Schwann cell and OEC	16347
S100 and P75	16376
these markers	16390
them	16425
cells can not be exclusively attributed to transplanted Schwann cells and/or OECs	16458
cells	16458
transplanted Schwann	16500
cells and/or OECs	16521
It	16540
P75 expression	16563
oligodendrocytes following spinal cord injury -LRB- 48 -RRB-	16591
oligodendrocytes	16591
spinal cord injury -LRB- 48 -RRB-	16618
spinal cord injury	16618
48	16638
the other hand	16650
gliosis	16666
the well-known proliferation of astrocytes which express S100 -LRB- 49 -RRB-	16677
the well-known proliferation	16677
astrocytes which express S100 -LRB- 49 -RRB-	16709
astrocytes	16709
S100	16734
49	16740
figure 1 , sparse positive staining of P75 and S100	16770
figure 1	16770
sparse positive staining of P75 and S100	16780
sparse positive staining	16780
P75 and S100	16808
the white matter of injury center	16824
the white matter	16824
injury center	16844
cell-treated groups	16861
integration of transplanted cells into the injury site	16891
integration	16891
transplanted cells into the injury site	16906
transplanted cells	16906
the injury site	16930
even this sparse labeling	16961
control group	17000
Current methods	17015
OECs	17058
its mixture with Schwann cells -LRB- 8,22,50,51 -RRB-	17068
its mixture	17068
Schwann cells -LRB- 8,22,50,51 -RRB-	17085
Schwann cells	17085
8,22,50,51	17100
This	17113
OECs	17147
lamina propria or olfactory nerve layer , which may raise Schwann contamination -LRB- 51,52 -RRB-	17171
lamina propria or olfactory nerve layer	17171
Schwann contamination -LRB- 51,52 -RRB-	17228
Schwann contamination	17228
51,52	17251
We	17259
OEC	17271
the olfactory bulb to minimize Schwann contamination	17280
Schwann contamination	17311
The timing of cell transplantation	17334
The timing	17334
cell transplantation	17348
an important issue	17377
acute transplantation	17400
better results -LRB- 53,54 -RRB-	17436
better results	17436
53,54	17452
the present study	17463
transplantation	17482
one week	17525
injury	17540
The first few hours following injury	17548
The first few hours	17548
injury	17578
this time	17618
the spinal cord	17628
secondary injury cascades -LRB- 55 -RRB-	17654
secondary injury cascades	17654
55	17681
exogenous cell transplantation	17715
Cotransplantation studies in acute phase	17747
Cotransplantation studies	17747
acute phase	17776
promising results -LRB- 34,56 -RRB-	17799
promising results	17799
34,56	17818
This study	17826
severe compression of the spinal cord	17857
severe compression	17857
the spinal cord	17879
subarachnoid transplantation of Schwann cell and/or OEC	17896
subarachnoid transplantation	17896
Schwann cell and/or OEC	17928
Schwann cell	17928
OEC	17948
motor performance	17969
other words	17991
the injury	18009
transplanted cells	18031
functional motor recovery	18064
it	18100
OEC or Schwann cell	18132
regeneration and recovery	18180
other models of spinal cord injury and transplantation , or higher concentration of cells	18212
other models of spinal cord injury and transplantation	18212
other models	18212
spinal cord injury and transplantation	18228
higher concentration of cells	18271
higher concentration	18271
cells	18295
The injured spinal cord	18302
one of the most hostile milieus for transplanted cells to survive	18329
one	18329
the most hostile milieus for transplanted cells to survive	18336
the most hostile milieus	18336
transplanted cells to survive	18365
the low density of cells in injection bolus	18406
the low density	18406
cells in injection bolus	18425
cells	18425
injection bolus	18434
higher densities	18451
the potential dispersion of cells in subarachnoid space	18508
the potential dispersion	18508
cells in subarachnoid space	18536
cells	18536
subarachnoid space	18545
the paucity of cell therapy studies through this route of transplantation	18572
the paucity	18572
cell therapy studies through this route of transplantation	18587
cell therapy studies	18587
this route of transplantation	18616
this route	18616
transplantation	18630
a definite conclusion	18647
studies to date	18693
studies	18693
date	18704
further research	18713
this field	18746
